These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29220513)

  • 1. Integrating 5hmC and gene expression data to infer regulatory mechanisms.
    Mitrea C; Wijesinghe P; Dyson G; Kruger A; Ruden DM; Draghici S; Bollig-Fischer A
    Bioinformatics; 2018 May; 34(9):1441-1447. PubMed ID: 29220513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.
    Bao B; Teslow EA; Mitrea C; Boerner JL; Dyson G; Bollig-Fischer A
    Mol Cancer Res; 2020 Dec; 18(12):1803-1814. PubMed ID: 32913111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Highly Sensitive and Robust Method for Genome-wide 5hmC Profiling of Rare Cell Populations.
    Han D; Lu X; Shih AH; Nie J; You Q; Xu MM; Melnick AM; Levine RL; He C
    Mol Cell; 2016 Aug; 63(4):711-719. PubMed ID: 27477909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlated 5-Hydroxymethylcytosine (5hmC) and Gene Expression Profiles Underpin Gene and Organ-Specific Epigenetic Regulation in Adult Mouse Brain and Liver.
    Lin IH; Chen YF; Hsu MT
    PLoS One; 2017; 12(1):e0170779. PubMed ID: 28125731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.
    Carella A; Tejedor JR; García MG; Urdinguio RG; Bayón GF; Sierra M; López V; García-Toraño E; Santamarina-Ojeda P; Pérez RF; Bigot T; Mangas C; Corte-Torres MD; Sáenz-de-Santa-María I; Mollejo M; Meléndez B; Astudillo A; Chiara MD; Fernández AF; Fraga MF
    Int J Cancer; 2020 Jan; 146(2):373-387. PubMed ID: 31211412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA.
    Skvortsova K; Zotenko E; Luu PL; Gould CM; Nair SS; Clark SJ; Stirzaker C
    Epigenetics Chromatin; 2017; 10():16. PubMed ID: 28428825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer.
    Peng D; Ge G; Gong Y; Zhan Y; He S; Guan B; Li Y; Xu Z; Hao H; He Z; Xiong G; Zhang C; Shi Y; Zhou Y; Ci W; Li X; Zhou L
    Clin Epigenetics; 2018 Jul; 10(1):94. PubMed ID: 30005692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
    Vishnubalaji R; Alajez NM
    Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
    Alberge JB; Magrangeas F; Wagner M; Denié S; Guérin-Charbonnel C; Campion L; Attal M; Avet-Loiseau H; Carell T; Moreau P; Minvielle S; Sérandour AA
    Clin Epigenetics; 2020 Nov; 12(1):163. PubMed ID: 33138842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
    Quintero M; Adamoski D; Reis LMD; Ascenção CFR; Oliveira KRS; Gonçalves KA; Dias MM; Carazzolle MF; Dias SMG
    BMC Cancer; 2017 Nov; 17(1):727. PubMed ID: 29115931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer.
    Storebjerg TM; Strand SH; Høyer S; Lynnerup AS; Borre M; Ørntoft TF; Sørensen KD
    Clin Epigenetics; 2018 Aug; 10(1):105. PubMed ID: 30086793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
    Zhong G; Lou W; Shen Q; Yu K; Zheng Y
    Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer.
    Jia R; Weng Y; Li Z; Liang W; Ji Y; Liang Y; Ning P
    Reprod Sci; 2021 Aug; 28(8):2331-2341. PubMed ID: 33650093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes.
    Nestor CE; Ottaviano R; Reddington J; Sproul D; Reinhardt D; Dunican D; Katz E; Dixon JM; Harrison DJ; Meehan RR
    Genome Res; 2012 Mar; 22(3):467-77. PubMed ID: 22106369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma.
    Fernandez AF; Bayón GF; Sierra MI; Urdinguio RG; Toraño EG; García MG; Carella A; López V; Santamarina P; Pérez RF; Belmonte T; Tejedor JR; Cobo I; Menendez P; Mangas C; Ferrero C; Rodrigo L; Astudillo A; Ortea I; Cueto Díaz S; Rodríguez-Gonzalez P; García Alonso JI; Mollejo M; Meléndez B; Domínguez G; Bonilla F; Fraga MF
    Hum Mol Genet; 2018 Sep; 27(17):3046-3059. PubMed ID: 29878202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
    Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
    Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.
    Roychowdhury A; Jondhale M; Saldanha E; Ghosh D; Kumar Panda C; Chandrani P; Mukherjee N
    Gene; 2021 Aug; 792():145728. PubMed ID: 34022297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.
    Azizgolshani N; Petersen CL; Chen Y; Levy JJ; Salas LA; Perreard L; Nguyen LN; Christensen BC
    Clin Epigenetics; 2021 Sep; 13(1):176. PubMed ID: 34538273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. oxBS-MLE: an efficient method to estimate 5-methylcytosine and 5-hydroxymethylcytosine in paired bisulfite and oxidative bisulfite treated DNA.
    Xu Z; Taylor JA; Leung YK; Ho SM; Niu L
    Bioinformatics; 2016 Dec; 32(23):3667-3669. PubMed ID: 27522082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.